DNA (STOCKS)
Ginkgo Bioworks Holdings, Inc.
$9.360100
+0.130100 (+1.41%)
Prev close: $9.230000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Jason Kelly
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $539.62M
- Employees
- 834
- P/E (TTM)
- -1.50
- P/B (TTM)
- 0.90
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
1
Buy
2
Hold
5
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.45 | $-1.25 | -0.1976 | -15.78% |
|
Jun 2025 (Q2)
|
$-1.10 | $-1.58 | +0.4823 | +30.48% |
|
Mar 2025 (Q1)
|
$-1.68 | $-1.79 | +0.1077 | +6.02% |
|
Dec 2024 (Q4)
|
$-2.00 | $-1.79 | -0.2123 | -11.88% |
Financial Statements
| Revenues | $180.61M |
| Benefits Costs and Expenses | $520.67M |
| Costs And Expenses | $520.67M |
| Operating Expenses | $528.74M |
| Depreciation and Amortization | $60.98M |
| Research and Development | $270.02M |
| Other Operating Expenses | $197.74M |
| Operating Income/Loss | -$348.13M |
| Income/Loss From Continuing Operations After Tax | -$339.55M |
| Income/Loss From Continuing Operations Before Tax | -$340.07M |
| Income Tax Expense/Benefit | -$519.00K |
| Net Income/Loss | -$339.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$339.55M |
| Net Income/Loss Available To Common Stockholders, Basic | -$339.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.18 |
| Diluted Earnings Per Share | -$6.18 |
| Basic Average Shares | 55,566,846 |
| Diluted Average Shares | 55,561,276 |
| Assets | $1.19B |
| Current Assets | $506.08M |
| Noncurrent Assets | $683.08M |
| Fixed Assets | $176.58M |
| Intangible Assets | $61.52M |
| Other Non-current Assets | $444.98M |
| Liabilities | $629.38M |
| Current Liabilities | $115.28M |
| Accounts Payable | $10.70M |
| Other Current Liabilities | $104.58M |
| Noncurrent Liabilities | $514.10M |
| Equity | $559.78M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $559.78M |
| Liabilities And Equity | $1.19B |
| Net Cash Flow From Operating Activities | -$165.82M |
| Net Cash Flow From Operating Activities, Continuing | -$165.82M |
| Net Cash Flow From Investing Activities | -$348.47M |
| Net Cash Flow From Investing Activities, Continuing | -$348.47M |
| Net Cash Flow From Financing Activities | $9.43M |
| Net Cash Flow From Financing Activities, Continuing | $9.43M |
| Exchange Gains/Losses | $280.00K |
| Net Cash Flow | -$504.58M |
| Net Cash Flow, Continuing | -$504.86M |
| Comprehensive Income/Loss | -$337.81M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$337.81M |
| Other Comprehensive Income/Loss | $1.73M |